Significant Developments:
Shougang Langze (02553)
The Hong Kong public offering of Shougang Langze shares was oversubscribed by approximately 1,421.54 times. The net proceeds from the global offering are estimated to be around HK$486 million.
CSPC Pharmaceutical Group (01093)
The company's first mRNA-LNP-based dual-target CAR-T cell injection (SYS6063 Injection) has received approval for clinical trials in China.
Haohai Biological Technology (06826)
A trifocal intraocular lens product developed by its controlling subsidiary has obtained a medical device registration certificate.
Man Wah Holdings (01999)
The company has proposed the listing of Ruimai Technology on the Beijing Stock Exchange.
Borrett Technology (01333)
Borrett Technology has entered into a strategic cooperation letter of intent with Zhida Technology (02650) to establish a long-term partnership in the fields of new energy engineering equipment and smart charging infrastructure.
PATEO (02889)
PATEO plans to collaborate with Ping An Capital to acquire an optoelectronic chip enterprise, aiming to extend its industrial chain into the upstream chip sector.
China Telecom (00728)
China Telecom is participating in establishing a quantum industry venture capital fund with a size of RMB 1.5 billion. QuantumCTek is contributing RMB 300 million for a 20% stake.
Tigermed (03347)
Tigermed intends to invest RMB 200 million to participate in a biomedical industry fund, focusing on innovative drugs and high-end medical devices.
China Literature (00772)
China Literature plans to invest over RMB 400 million to acquire an additional approximately 28.22% equity stake in Wuhan Yihua Kaitian Culture Communication Co., Ltd.
Datang International Power Generation (00991)
Over the past month, the company's A-share stock price has accumulated an increase of approximately 120.67%, with its price-to-book ratio exceeding the industry average.
Operational Performance:
Jinchuan International (02362)
In the first quarter, the mining business produced approximately 18,000 tonnes of copper, representing an increase of about 29.5% year-on-year.
Agile Group (03383)
The aggregate pre-sales amount for the first five months was approximately RMB 2.98 billion, a decrease of 29.72% compared to the same period last year.
Comments